Navigation Links
New Vision Device Passes Virtual Collision Test for People with Tunnel Vision

BOSTON, Aug. 31 /PRNewswire/ -- A high-tech device that expands the visual field of patients with tunnel vision has passed a collision test in a walking simulator, according to scientists at Schepens Eye Research Institute, in a study published in the September issue of Investigative Ophthalmology and Visual Science. The study found that patients wearing this innovative device, consisting of a tiny camera, pocket-sized computer and a transparent computer display on a pair of glasses, were able to correctly judge potential collisions when "walking" in a virtual shopping mall. (Incorrect judgment could result in over reaction and actually contribute to an accident.)

"This is additional evidence that these glasses can help people with this debilitating condition," says Dr. Eli Peli, who invented them several years ago and has been testing and refining them ever since.

In previous research, Peli and his team found that the glasses significantly improved a person's ability to detect objects not in his/her visual field. The current study is the first to test the glasses while a person is in a potential collision situation.

Approximately one in 50 Americans over age 40 suffers from an eye disease, such as glaucoma or retinitis pigmentosa, that can lead to tunnel vision. Tunnel vision occurs when peripheral or side vision is destroyed, leaving only a small window of central vision. Tunnel vision can often cause the individual to bump into or trip over obstacles. "Navigating city streets or buildings can be quite challenging," says Dr. Peli.

To deal with tunnel vision, patients have relied on long canes to warn them of obstacles just in front of them. Glasses that act as reverse binoculars, miniaturizing and pulling in the missing parts of their visual field, have been tried in the past, but made things so small that detailed visual information is sacrificed.

With Peli's glasses, the transparent display allows patients to retain their ability to see detailed visual information, while also viewing a superimposed minified outline version of a wider visual field. The tiny computer-video system provides updated outline information 30 times per second. When a patient becomes aware of a possible obstacle or important object in the superimposed outline image, he/she can avoid bumping into or tripping over it.

Because the minified outline can strongly distort perception of distance and obstacle location, and only provides coarse information about the scene, Peli and his team wanted to know if patients were able to use the device to make correct judgments about potential collisions. They tested normally sighted subjects and tunnel vision patients in a large virtual mall environment that presented a series of collision scenarios -- people and objects appearing from different distances and directions. They asked the subjects to estimate the risk of collision in these scenarios with and without wearing the tunnel vision device.

The team found that, even without any adaptation or training, all tested subjects were able to make decisions using the device as accurately as when directly looking at obstacles with natural vision. The distortion of minification did not seem to affect their judgment.

The research team, which includes Dr. Gang Luo and Dr. Russell L. Woods, says that the next step is to refine the device and evaluate its utility in patients' daily life.

"From this study, we had an idea about how we could make an intelligent collision detection system. We have started to develop such a system that can automatically provide warnings about potential collisions. It can help patients with tunnel vision, as well as completely blind people," says Dr. Luo.

Schepens Eye Research Institute is the largest independent eye research institute in the nation and an affiliate of Harvard Medical School.

SOURCE Schepens Eye Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmaTelevision Launches the First Daily News Show for the Life Sciences Industry
2. Trusted LASIK Surgeons Welcomes Fort Lauderdale Vision Correction Surgery Expert Raymond P. Gailitis, M.D., F.A.C.S.
3. One of the Nation's Leading Analytical Testing Laboratories is Now Easier to Access -- Pace Analytical Launches New Web Site to Showcase Its Three Business Divisions
4. Seasoned Dermatologist Nissan Pilest of Irvine, CA, Joins SDS Clinical Trials as Clinical Investigator for Dermatology Division
5. Environmental Tectonics Corporation Announces Promotion of Don R. Webber to VP of Sales for their BioMedical Division
6. avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign
7. Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster
8. Environmental Tectonics Corporations BioMedical Division to Exhibit at Undersea and Hyperbaric Medical Society Meeting
9. Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan
10. Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections
11. Leading for Growth in the New Economic Reality Includes Vision and Innovation
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... company uBiome, were featured on AngelList early in their initial angel funding process. ... AngelList syndicate for individuals looking to make early stage investments in the microbiome ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
(Date:11/24/2015)... , November 24, 2015 ... market research report "Oligonucleotide Synthesis Market by Product & ... Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & ... by MarketsandMarkets, the market is expected to reach USD ... 2015, at a CAGR of 10.1% during the forecast ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/12/2015)... , Nov. 11, 2015   Growing ... reliable analytical tools has been paving the way ... qualitative determination of discrete analytes in clinical, agricultural, ... are being predominantly used in medical applications, however, ... environmental sectors due to continuous emphasis on improving ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):